clinical trial phase - Robuta Search

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-trial-phase Definition of clinical trial phase - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. clinical trial phase definition of nci dictionary cancer https://www.uclahealth.org/clinical-trials/phase-2-study-evaluating-rapcabtagene-autoleucel Autoimmune Disorders UCLA Clinical Trial | Phase 2 Study Evaluating Rapcabtagene Autoleucel in... clinical trial phase autoimmune disorders https://givebutter.com/L437Hz Mistletoe Clinical Trial - Phase II | BELIEVE BIG INC clinical trial phase mistletoe ii believe big https://www.brusselstimes.com/news/belgium-all-news/health/145370/curevac-launches-third-clinical-trial-phase-for-covid-19-vaccine-franz-werner-haas-pfizer-biontech-mhra-fda/ Curevac launches third clinical trial phase for Covid-19 vaccine Curevac's coronavirus vaccine will enter its third phase of clinical trials, the German pharmaceutical laboratory announced on Monday. clinical trial phase covid 19 curevac launches third https://axisclinicalsusa.com/ Clinical Research Center for Phase 1 Clinical Trials | Early Phase Trial Unit Trusted clinical research center offering Phase I trials, early phase 1 clinical trials, and complete early phase clinical development services through a... clinical research center phase 1 trials early unit https://www.techtarget.com/pharmalifesciences/news/366607088/Novartis-Cancer-Treatment-Fails-in-Phase-3-Clinical-Trial Novartis Cancer Treatment Fails in Phase 3 Clinical Trial | TechTarget Novartis cancer treatment Kymriah did not meet its primary endpoint of event-free survival compared to treatment with the standard-of-care in the Phase 3... phase 3 clinical trial cancer treatment novartis fails techtarget https://www.biospace.com/press-releases/allarity-therapeutics-announces-expansion-of-phase-2-clinical-trial-to-accelerate-development-of-stenoparib-in-advanced-ovarian-cancer Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of... phase 2 clinical trial expansion of https://www.businesswire.com/news/home/20201201005539/en/Turnstone-Biologics-Announces-First-Patients-Enrolled-in-Phase-12-Clinical-Trial-Evaluating-RIVAL-01-For-the-Treatment-of-Solid-Tumors Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating... Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of engineered viral immunotherapies, today announced enrollment ... https://www.biospace.com/cerevel-therapeutics-initiates-phase-1b-clinical-trial-of-cvl-231-a-m4-selective-positive-allosteric-modulator-in-development-for-the-treatment-of-schizophrenia Cerevel Therapeutics Initiates Phase 1b Clinical Trial of CVL-231, a M4 Selective Positive... Oct 22, 2019 - Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today it has dosed the first... https://www.biospace.com/elevation-oncology-expands-ongoing-phase-1-clinical-trial-of-eo-3021-globally-dosing-first-patient-in-japan Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient... Feb 22, 2024 - Elevation Oncology, Inc. today announced that it has expanded its ongoing Phase 1 clinical trial of EO-3021 outside the United States, dosing the first patient... phase 1 clinical trial https://www.biospace.com/press-releases/lyell-immunopharma-announces-oral-presentation-of-new-clinical-data-from-the-phase-1-2-trial-of-lyl314-for-the-treatment-of-large-b-cell-lymphoma-at-the-international-conference-on-malignant-lymphoma-icml-2025 Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of... https://www.biospace.com/biolinerx-announces-initiation-of-phase-1b-clinical-trial-in-patients-with-acute-respiratory-distress-syndrome-ards-secondary-to-covid-19-and-other-respiratory-viral-infections BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory... Nov 18, 2020 - - Investigator-initiated study, led by Wolfson Medical Center, to evaluate Motixafortide in up to 25 patients hospitalized with ARDS - - Results of preliminary... https://www.biospace.com/clearmind-medicine-obtains-ind-approval-from-the-fda-to-start-the-phase-i-iia-clinical-trial-with-its-innovative-treatment-for-alcoholism Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with... https://www.businesswire.com/news/home/20250122193446/en/Humanetics-Corporation-Announces-Positive-Phase-2-Clinical-Trial-Results-in-COVID-19-Study-Aimed-at-Improving-Pulmonary-Function Humanetics Corporation Announces Positive Phase 2 Clinical Trial Results in COVID-19 Study Aimed at... This release details preliminary results from a phase II clinical trial of BIO 300. phase 2 clinical trial https://www.biospace.com/polypid-announces-positive-top-line-results-from-phase-2-clinical-trial-of-d-plex100-for-the-prevention-of-surgical-site-infections-in-abdominal-surgery PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the... Oct 17, 2019 - D-PLEX100 Administration into the Surgical Site Led to Statistically Significant Reduction in Infections Compared to Standard of Care Alone https://www.prnewswire.com/news-releases/conatus-pharmaceuticals-terminates-phase-2-clinical-trial-of-cts-1027-132545253.html Conatus Pharmaceuticals Terminates Phase 2 Clinical Trial of CTS-1027 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the termination of its Phase 2 clinical trial of CTS-1027 in HCV patients. This decision follows... phase 2 clinical trial conatus pharmaceuticals cts 1027 https://www.biospace.com/press-releases/keros-therapeutics-announces-initial-topline-results-from-the-phase-1-clinical-trial-of-ker-065-in-healthy-volunteers Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in... https://www.biospace.com/acticor-biotech-completed-its-phase-i-clinical-trial-with-act017-achieving-its-safety-and-tolerability-primary-endpoints Acticor Biotech Completed Its Phase I Clinical Trial with ACT017 Achieving Its Safety and... Feb 5, 2018 - The primary endpoint assessing safety and tolerability was achieved with no serious adverse event reported at any of the doses tested. phase i clinical trial https://www.biospace.com/menlo-therapeutics-presents-successful-phase-2-clinical-trial-results-of-serlopitant-in-psoriasis-at-the-european-academy-of-dermatology-and-venereology-meeting Menlo Therapeutics Presents Successful Phase 2 Clinical Trial Results of Serlopitant in Psoriasis... Oct 11, 2019 - Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, presented results from its successful Phase 2 clinical trial of serlopitant for... phase 2 clinical trial https://www.prnewswire.com/news-releases/lipocine-provides-progress-update-on-lpcn-1154-phase-3-clinical-trial-in-postpartum-depression-ppd-302570209.html Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD) /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with... https://www.prnewswire.com/news-releases/altesa-biosciences-enrolls-first-patient-in-phase-2b-cardinal-clinical-trial-evaluating-vapendavir-as-transformational-treatment-for-patients-with-copd-impacted-by-rhinovirus-the-leading-cause-of-exacerbations-302762079.html?tc=eml_cleartime Altesa BioSciences Enrolls First Patient in Phase 2b CARDINAL Clinical Trial Evaluating Vapendavir... /PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including... https://www.biospace.com/acurx-announces-positive-extended-clinical-cure-data-for-ibezapolstat-from-phase-2b-clinical-trial-in-cdi-patients Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial... Jan 29, 2024 - Acurx Pharmaceuticals, Inc. today announced positive extended clinical cure (ECC) data for ibezapolstat (IBZ), its lead antibiotic candidate, from the... https://www.prnewswire.co.uk/news-releases/photocure-partner-asieris-announces-approval-to-conduct-a-phase-iii-clinical-trial-for-hexvix-in-china-874974755.html Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Trial for Hexvix in... /PRNewswire/ -- Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has obtained the Phase... https://www.biospace.com/aviadobio-announces-initiation-of-phase-1-2-clinical-trial-aspire-ftd-evaluating-avb-101-in-people-with-frontotemporal-dementia-with-grn-mutations AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in... Oct 10, 2023 - AVB-101 is an investigational gene therapy designed to halt disease progression by delivering a functional copy of the GRN gene to restore appropriate... https://www.biospace.com/kineta-announces-first-participant-dosed-in-phase-1-clinical-trial-of-kcp506-a-novel-non-opioid-for-the-treatment-of-chronic-pain Kineta Announces First Participant Dosed in Phase 1 Clinical Trial of KCP506, A Novel Non-Opioid... Dec 15, 2020 - Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the first participant has been successfully dosed in a Phase 1 clinical trial... https://www.prnewswire.com/news-releases/alkahest-doses-first-subject-in-phase-2-clinical-trial-of-lead-candidate-in-patients-with-severe-alzheimers-disease-300813375.html Alkahest Doses First Subject in Phase 2 Clinical Trial of Lead Candidate in Patients with Severe... /PRNewswire/ -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today... https://stockhouse.com/news/press-releases/2024/03/07/vaxxinity-announces-positive-target-engagement-data-from-phase-1-clinical-trial 2024-03-07 | Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for... (2024-03-07 | EXPM:VAXX) Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD(TM) 2024 https://stockhouse.com/news/press-releases/2026/03/26/novocure-announces-positive-topline-results-from-phase-2-panova-4-clinical-trial 2026-03-26 | Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of... (2026-03-26 | NDAQ:NVCR) Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for... https://investingnews.com/nurix-therapeutics-announces-webcast-to-review-new-and-updated-data-from-the-phase-1-clinical-trial-of-btk-degrader-bexobrutideg-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeti/ Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial... Dec 1, 2025 - Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted... https://www.prnewswire.com/news-releases/mindmed-receives-fda-type-c-meeting-response-for-project-lucy-phase-2b-clinical-trial-301292298.html MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial /PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announces receipt of Type C Meeting... https://www.biospace.com/synthetic-biologics-inc-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-syn-004-for-the-prevention-of-c-difficile-infection Synthetic Biologics, Inc. Announces First Patient Dosed In Phase 1b Clinical Trial Of SYN-004 For... https://www.businesswire.com/news/home/20260413254076/en/Enanta-Pharmaceuticals-Announces-First-Participant-Dosed-in-Phase-1-Clinical-Trial-of-EDP-978-an-Oral-Once-Daily-KIT-Inhibitor-in-Development-for-the-Treatment-of-Urticaria Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an... Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immuno... https://www.businesswire.com/news/home/20260209315923/en/VectorY-Therapeutics-Announces-First-Participant-Dosed-in-Phase-12-PIONEER-ALS-Clinical-Trial-of-VTx-002-in-People-with-Amyotrophic-Lateral-Sclerosis-ALS?dm_i=40VQ,1RZ6S,73ZN21,710VW,1,0,0,0 VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of... VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in ... https://investingnews.com/alzamend-neuro-reports-encouraging-pharmacodynamic-data-from-phase-ii-clinical-trial-of-al001-lithium-in-brain-study-in-a-trial-conducted-at-massachusetts-general-hospital/ Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001... Apr 7, 2026 - Potentially Distinct Brain Profile: Across multiple brain regions, AL001 and lithium carbonate appeared to trend in opposite directions in brain chemistry... phase ii clinical trial https://www.sciencetimes.com/articles/47919/20231228/new-antibiotic-against-hospital-acquired-superbug-c-diff-shows-promise.htm New Antibiotic Against Hospital-Acquired Superbug C. diff Shows Promise in Phase-One Clinical Trial Dec 28, 2023 - Omadacycline, a new antibiotic, shows promise in phase-one trial against hospital-acquired superbug C. diff. Continue reading to learn more details. https://www.researchandmarkets.com/reports/5744662/multiple-sclerosis-clinical-trial-analysis-trial Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points,... Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update multiple sclerosis clinical trial by phase analysis https://www.businesswire.com/news/home/20230323005287/en/GRIN-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1B-Clinical-Trial-with-Radiprodil-for-Treatment-of-GRIN-related-Disorders GRIN Therapeutics Announces First Patient Dosed in Phase 1B Clinical Trial with Radiprodil for... GRIN Therapeutics Inc. Announces First Patient Dosed in Phase 1B Clinical Trial with Radiprodil for Treatment of GRIN-related Disorders. https://www.biospace.com/kangpu-biopharmaceuticals-initiates-phase-ib-iia-clinical-trial-of-kpg-818-in-systemic-lupus-erythematosus Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus... Nov 17, 2020 - Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China , announced that, after consulting with the U.S. Food and Drug Administration... https://www.biospace.com/soligenix-announces-positive-recommendation-by-data-review-committee-on-its-phase-2-clinical-trial-of-sgx942-for-the-treatment-of-oral-mucositis-in-he Soligenix Announces Positive Recommendation By Data Review Committee On Its Phase 2 Clinical Trial... https://www.prnewswire.com/news-releases/aileron-therapeutics-to-present-previously-announced-data-from-the-phase-1b-clinical-trial-evaluating-low-dose-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-at-the-22nd-international-colloquium-on-lung-and-airway-fibrosis-302274268.html Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial... /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to... https://sciencedaily.com/releases/2024/05/240520180527.htm Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2... Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- that showed rapid and sustained... https://www.biospace.com/press-releases/alzamend-neuro-announces-initiation-date-of-phase-ii-clinical-trial-of-al001-for-treatment-of-bipolar-disorder-to-take-place-at-massachusetts-general-hospital Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of... phase ii clinical trial https://menafn.com/1109431943/ORYZON-Announces-First-Patient-Dosed-In-NCI-Sponsored-Phase-III-Clinical-Trial-Of-Iadademstat-Plus-Immune-Checkpoint-Inhibitors-In-1L-Extensive-Stage-Small-Cell-Lung-Cancer ORYZON Announces First Patient Dosed In NCI-Sponsored Phase I/II Clinical Trial Of Iadademstat Plus... ORYZON Announces First Patient Dosed In NCI-Sponsored Phase I/II Clinical Trial Of Iadademstat Plus Immune Checkpoint Inhibitors In 1L Extensive Stage Small... https://www.biospace.com/global-phase-2-3-clinical-trial-for-covid-19-vaccine-starts-at-nyu-langone-health Global Phase 2/3 Clinical Trial for COVID-19 Vaccine Starts at NYU Langone Health - BioSpace Jul 28, 2020 - The first U.S. patients are being dosed today and tomorrow in a Phase 2/3 clinical trial testing whether a messenger RNA (mRNA) vaccine candidate can prevent... https://www.businesswire.com/news/home/20210302005028/en/Pipeline-Therapeutics-Initiates-Phase-1-Clinical-Trial-of-PIPE-307 Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307 Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307 phase 1 clinical trial pipeline therapeutics initiates 307 https://www.prnewswire.com/news-releases/bonnie-j-addario-lung-cancer-foundation-launches-second-phase-of-180000-clinical-trial-innovation-prize-300215371.html Bonnie J. Addario Lung Cancer Foundation Launches Second Phase of $180,000 Clinical Trial... /PRNewswire-USNewswire/ -- Each year, in honor of World Cancer Day, the Bonnie J. Addario Lung Cancer Foundation (ALCF) launches a unique, international... bonnie j addario https://www.news-medical.net/news/20100729/Positive-results-from-phase-I-clinical-trial-of-MultiStem-in-patients-with-AMI-announced.aspx Positive results from phase I clinical trial of MultiStem in patients with AMI announced Jun 19, 2019 - Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced positive results from its phase I clinical trial of MultiStem, its allogeneic cell therapy... phase i clinical trial https://www.prnewswire.com/news-releases/ph-d-feminine-health-launches-first-fda-cleared-phase-3-clinical-trial-for-boric-acid-suppositories-302528102.html pH-D Feminine Health Launches First FDA-Cleared Phase 3 Clinical Trial for Boric Acid Suppositories /PRNewswire/ -- pH-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to... https://pmc.ncbi.nlm.nih.gov/articles/PMC8290991/ Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial... Financial compensation for research participation is a major focus of ethical concern regarding human subject recruitment. Phase I trials are sometimes... phase i trial https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/cytokinetics-announces-start-of-phase-2-clinical-trial-of-ck-3773274/ Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-3773274 | INN Jan 2, 2026 - Cytokinetics (NASDAQ:CYTK) announced that REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM) has opened to... phase 2 clinical trial cytokinetics announces start https://www.biospace.com/inxmed-receives-approval-to-initiate-phase-i-clinical-trial-in-china-for-omtx705-a-first-in-class-fap-targeting-adc InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class... Aug 30, 2023 - InxMed announced the first-in-class ADC OMTX705 has obtained the IND approval from China National Medical Products Administration recently. https://www.biospace.com/immupharma-plc-update-on-progress-of-phase-i-iia-clinical-trial ImmuPharma plc - Update on Progress of Phase I/IIa Clinical Trial - BioSpace on progress https://www.biospace.com/vitrac-therapeutics-to-present-phase-1-clinical-trial-design-on-novel-aurora-kinase-a-inhibitor-vic-1911-and-g12c-inhibitor-sotorasib-for-kras-g12c-mutant-non-small-cell-lung-cancer-at-the-2023-asco-annual-meeting VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor,... Jun 5, 2023 - VITRAC Therapeutics, LLC presented a poster on the Phase 1a/1b clinical trial of aurora kinase A inhibitor, VIC-1911, as monotherapy and in combination with... phase 1 clinical trial https://www.prweb.com/releases/intrinsic_imaging_awarded_international_phase_ii_clinical_trial_for_chronic_iron_overload/prweb10968852.htm Intrinsic Imaging Awarded International Phase II Clinical Trial for Chronic Iron Overload Boston, MA, San Antonio, TX (PRWEB) July 29, 2013 -- Intrinsic Imaging, an FDA audited, ISO 9001:2008 and ISO 13485 certified medical imaging core lab... phase ii clinical trial https://www.biospace.com/kymera-therapeutics-to-present-new-clinical-data-from-the-ongoing-phase-1-trial-of-stat3-degrader-kt-333-at-eha-annual-meeting Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader... May 15, 2024 - Kymera Therapeutics, Inc. announced that new Phase 1 data for KT-333, a first-in-class degrader of STAT3, highlighting safety, pharmacokinetics,... https://www.news-medical.net/news/20221212/Ongoing-Phase-I-clinical-trial-demonstrates-successful-re-treatment-with-CAR-T-cell-therapy.aspx Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy Dec 12, 2022 - Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating... phase i clinical trial https://www.biospace.com/f-star-therapeutics-announces-first-patient-dosed-in-fs222-phase-1-clinical-trial F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial - BioSpace Jan 4, 2021 - F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the... phase 1 clinical trial https://www.biospace.com/statera-biopharma-submits-phase-3-clinical-trial-protocol-to-fda-for-investigational-treatment-of-pediatric-crohn-s-disease Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of... Dec 29, 2021 - Statera Biopharma, Inc. today announced submission to the U.S. Food and Drug Administration (FDA) of its Phase 3 clinical trial protocol for STAT-201 in the... phase 3 clinical trial https://www.financialcontent.com/article/gnwcq-2025-3-5-atai-life-sciences-announces-completion-of-enrollment-in-phase-2b-clinical-trial-evaluating-bpl-003-for-treatment-resistant-depression atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003... - The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and safety of a single dose of BPL-003... https://www.biospace.com/arvinas-and-pfizer-announce-updated-clinical-data-from-phase-1b-trial-of-vepdegestrant-in-combination-with-palbociclib-ibrance Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in... May 16, 2024 - Arvinas, Inc. and Pfizer Inc. announced updated clinical data from a Phase 1b combination cohort evaluating vepdegestrant, an investigational oral PROteolysis... https://www.mdpi.com/2076-393X/11/12/1767 A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine... mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played a key role in reducing morbidity and mortality from coronavirus... https://www.biospace.com/cerus-corporation-initiates-phase-i-clinical-trial-for-crs-100 Cerus Corporation Initiates Phase I Clinical Trial For CRS-100 - BioSpace phase i clinical trial cerus corporation initiates https://www.biospace.com/capricor-therapeutics-inc-completes-enrollment-of-phase-ii-clinical-trial-for-cenderitide-to-treat-heart-failure Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To... phase ii clinical trial https://www.biospace.com/press-releases/lb-pharmaceuticals-presents-new-data-from-phase-2-clinical-trial-of-lb-102-at-the-2025-annual-congress-of-the-schizophrenia-international-research-society LB Pharmaceuticals Presents New Data from Phase 2 Clinical Trial of LB-102 at the 2025 Annual... https://www.researchandmarkets.com/reports/5595419/marfan-syndrome-clinical-trial-analysis-by Marfan Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region,... Marfan Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update https://www.biospace.com/evelo-biosciences-reports-positive-topline-clinical-data-in-phase-1b-trial-of-edp1815-in-atopic-dermatitis Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic... Dec 9, 2020 - Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered product candidates which act in the... https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/progressive-supranuclear-palsy-phase-2-platform-clinical-trial-announ-1019112 Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1... LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of... https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-completion-of-target-enrollment-in-rezolve-aa-phase-2b-clinical-trial-of-rezpegaldesleukin-in-patients-with-severe-to-very-severe-alopecia-areata-302385779.html Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial... /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of... https://www.biospace.com/kamada-announces-enrollment-of-first-patient-into-its-pivotal-phase-3-innovaate-clinical-trial-of-inhaled-aat-for-the-treatment-of-alpha-1-antitrypsin-deficiency Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of... https://pmc.ncbi.nlm.nih.gov/articles/PMC4015229/ Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant... Reovirus, an oncolytic RNA virus exhibiting antiglioma activity, was shown in a previous single institution phase 1 study found that the inoculation of the... phase 1 clinical trial https://www.prnewswire.com/news-releases/cytrx-corporation-highlights-positive-results-from-full-data-set-of-phase-23-clinical-trial-in-niemann-pick-disease-type-c-npc-conducted-by-arimoclomol-licensee-orphazyme-as-300790614.html CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in... /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, highlighted positive Phase... https://www.biospace.com/celcuity-inc-announces-plan-to-initiate-a-phase-3-clinical-trial-for-gedatolisib-as-first-line-treatment-for-hr-her2-advanced-breast-cancer-and-secures-approximately-62-million-debt-financing Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line... Jul 30, 2024 - Celcuity Inc. announced that it plans to initiate a Phase 3 clinical trial to evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line... https://www.biospace.com/adc-therapeutics-announces-first-patient-dosed-in-pivotal-phase-2-portion-of-lotis-3-clinical-trial-of-loncastuximab-tesirine-lonca-in-combination-with-ibrutinib ADC Therapeutics Announces First Patient Dosed in Pivotal Phase 2 Portion of LOTIS 3 Clinical Trial... Jul 17, 2020 - Combination is being evaluated in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or mantle cell lymphoma (MCL) https://www.digitaljournal.com/pr/news/skye-bioscience-doses-second-cohort-of-phase-1-clinical-trial-of-sbi-100-ophthalmic-emulsion Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion phase 1 clinical trial https://www.biospace.com/axial-therapeutics-announces-completion-of-enrollment-in-global-phase-2b-clinical-trial-for-ab-2004-for-irritability-associated-with-autism Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004... Sep 26, 2023 - Axial Therapeutics today announced completion of enrollment in the TAPESTRY Autism Study, the Phase 2b clinical trial of its lead product candidate, AB-2004, a... https://www.sciencetimes.com/articles/39251/20220808/pfizer-valneva-se-working-together-third-phase-clinical-trial-lyme.htm Pfizer and Valneva SE Are Working Together for the Third Phase Clinical Trial of Lyme Disease... Aug 8, 2022 - The clinical trial for the Lyme disease vaccine will include approximately 6,000 participants aged five and above from some regions in Europe and the US. Read... https://www.roche.com/investors/updates/inv-update-2020-07-13c Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A... Dear Investor, Please find attached a press release by Spark Therapeutics: https://sparktx.com/press_releases/isth2020/ Do not hesitate to contact us for any... https://www.biospace.com/novavax-initiates-pediatric-expansion-for-phase-3-clinical-trial-of-covid-19-vaccine Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine - BioSpace May 3, 2021 - Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has... phase 3 clinical trial https://www.biospace.com/trovagene-announces-activation-of-two-additional-clinical-trial-sites-to-conduct-its-phase-1b-2-study-of-pcm-075-in-patients-with-aml Trovagene Announces Activation of Two Additional Clinical Trial Sites to Conduct its Phase Ib/II... Feb 13, 2018 - The trial, which is being led by hematologist Jorge Cortes, M.D., Deputy Department Chair, Department of Leukemia, Division of Cancer Medicine, The University... https://www.biospace.com/hibercell-to-collaborate-with-merck-on-phase-2-clinical-trial-of-odetiglucan-in-combination-with-keytruda-pembrolizumab-in-patients-with-metastatic-breast-cancer HiberCell to Collaborate with Merck on Phase 2 Clinical Trial of Odetiglucan in Combination with... Dec 15, 2021 - HiberCell announced a clinical trial collaboration with Merck, known as MSD outside of the United States and Canada. phase 2 clinical trial https://www.prnewswire.com/news-releases/idri-and-medicago-announce-fda-authorization-to-initiate-a-phase-1-clinical-trial-for-an-h5n1-vaccine-with-gla-adjuvant-166384066.html IDRI and Medicago Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1... /PRNewswire/ - The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants... https://www.businesswire.com/news/home/20251209988664/en/Ventus-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-VENT-03-a-Novel-Small-Molecule-cGAS-Inhibitor-in-Patients-with-Lupus Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel... Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for immunological, inflammatory, and neurological ... https://www.biospace.com/b-wex-b-initiates-phase-iia-clinical-trial-of-tetrodin-tm-for-reduction-of-withdrawal-symptoms-in-opiate-dependent-patients Wex Initiates Phase IIa Clinical Trial Of Tetrodin"TM" For Reduction Of Withdrawal Symptoms In... https://www.researchandmarkets.com/reports/6062594/clinical-trial-central-laboratory-services Clinical Trial Central Laboratory Services Market Size, Share & Trends Analysis Report By Phase... The Clinical Trial Central Laboratory Services Market, valued at USD 4.03B in 2024, is projected to reach USD 6.97B by 2030, growing at a 9.8% CAGR. central laboratory services https://www.biospace.com/phase-ii-colorectal-cancer-clinical-trial-first-to-receive-support-scientific-oversight-from-van-andel-institute-stand-up-to-cancer-epigenetics-dream Phase II Colorectal Cancer Clinical Trial First To Receive Support, Scientific Oversight From Van... https://www.biospace.com/biondvax-announces-rights-offering-in-support-of-ongoing-pivotal-clinical-efficacy-phase-3-trial-of-the-m-001-universal-flu-vaccine-and-scale-up-of-manufacturing-process BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial... Jun 10, 2019 - The Company anticipates results of the Phase 3 trial will be announced by the end of 2020. https://www.biospace.com/entera-bio-ltd-announces-completion-of-enrollment-in-phase-2-clinical-trial-of-eb613-in-osteoporosis Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In... Nov 9, 2020 - Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced the completion of enrollment in the... phase 2 clinical trial https://www.biospace.com/press-releases/kezar-life-sciences-announces-fda-has-lifted-partial-clinical-hold-on-portola-phase-2a-trial-evaluating-zetomipzomib-for-the-treatment-of-patients-with-autoimmune-hepatitis Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial... https://www.prnewswire.com/news-releases/phoenix-molecular-designs-receives-fda-clearance-to-begin-phase-11b-clinical-trial-with-pmd-026-a-first-in-class-rsk-inhibitor-targeting-advanced-breast-cancer-300922795.html Phoenix Molecular Designs Receives FDA Clearance to Begin Phase 1/1b Clinical Trial with PMD-026, a... /PRNewswire/ -- Phoenix Molecular Designs (PhoenixMD), a clinical stage biotechnology company developing precise cancer therapeutics targeting essential... https://www.uclahealth.org/clinical-trials/phase-1-study-cpo301-adult-patients-with-advanced-or Adolescent & Young Adults (AYA) UCLA Clinical Trial | A Phase 1 Study of CPO301 in Adult Patients... https://www.biospace.com/china-shenghuo-pharmaceutical-holdings-inc-announces-closing-of-phase-ii-clinical-trial-for-wei-dingkang-soft-capsules China Shenghuo Pharmaceutical Holdings, Inc. Announces Closing of Phase II Clinical Trial for Wei... phase ii clinical trial https://www.fhi.no/en/projects/cancer/gardasil-9-ltfu-v503/ LTFU V503: Long-Term Follow-Up of Women Participating in the Phase III Clinical Trial with the... This long-term study of the Gardasil 9 vaccine will provide information about the vaccine's safety, protection, and duration for up to 14 years after... https://kffhealthnews.org/morning-breakout/dr00031430/ Indian Government Approves Second HIV Vaccine for Phase I Clinical Trial - KFF Health News Indian Government Approves Second HIV Vaccine for Phase I Clinical Trial phase i clinical trial https://www.businesswire.com/news/home/20231115320093/en/Orionis-Biosciences-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ORB-011-in-Patients-with-Advanced-Solid-Tumors Orionis Biosciences Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011 in Patients... Orionis Biosciences, a life sciences company pioneering the creation of highly selective and tunable therapeutics for cancer and other diseases, today announ... https://www.businesswire.com/news/home/20250806585386/en/PolyActiva-Announces-First-Patient-Enrolled-in-US-Phase-2b-Clinical-Trial-of-its-Ocular-Micro-Implant-for-Glaucoma-and-Ocular-Hypertension PolyActiva Announces First Patient Enrolled in US Phase 2b Clinical Trial of its Ocular Micro... PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, t... https://www.prnewswire.com/news-releases/gyala-therapeutics-initiates-phase-iiia-clinical-trial-of-a-car-t-cell-therapy-in-acute-leukemias-with-limited-treatment-options-302681392.html Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias... /PRNewswire/ -- Gyala Therapeutics, a clinical-stage biotechnology company developing innovative cell therapies for hematologic malignancies, today announced... https://www.biospace.com/jazz-pharmaceuticals-inc-announces-phase-iii-clinical-trial-to-study-the-safety-and-efficacy-of-xyrem-r-sodium-oxybate-in-patients-with-fibromyal Jazz Pharmaceuticals, Inc. Announces Phase III Clinical Trial To Study The Safety And Efficacy Of... phase iii clinical trial https://www.businesswire.com/news/home/20240307706540/en/Upstream-Bio-Initiates-a-Phase-2-Clinical-Trial-of-Verekitug-UPB-101-in-Severe-Asthma-and-Doses-First-Patients Upstream Bio Initiates a Phase 2 Clinical Trial of Verekitug (UPB-101) in Severe Asthma and Doses... Upstream Bio announces the dosing of the first patients in its Phase 2 VALIANT clinical trial of verekitug (UPB-101) in patients with severe asthma. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-3-clinical-trial Definition of phase 3 clinical trial - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. phase 3 clinical trial definition of nci dictionary cancer